Browse
Browse and Search
Search
Explore more content
12933_2021_1258_MOESM1_ESM.
docx
(14.9 kB)
File info
This item contains files with download restrictions
Fullscreen
Additional file 1 of Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study
Cite
Download
(14.9 kB)
Share
Embed
journal contribution
posted on 2021-03-23, 05:12
authored by
Moa Lugner
,
Naveed Sattar
,
Mervete Miftaraj
,
Jan Ekelund
,
Stefan Franzén
,
Ann-Marie Svensson
,
Björn Eliasson
Additional file 1. Table with definitions of the different outcome categories used in the analyses.
Funding
University of Gothenburg
History
Usage metrics
Categories
Medicine
Physiology
Pharmacology
Biotechnology
Chemical Sciences not elsewhere classified
Immunology
Keywords
Type 2 diabetes
Epidemiology
Sodium glucose transporter 2 inhibitors
Glucagon‐like peptide-1 receptor agonist
Mortality
Cardiovascular disease
Licence
CC BY + CC0
Exports
Select an option
RefWorks
RefWorks
BibTeX
BibTeX
Ref. manager
Ref. manager
Endnote
Endnote
DataCite
DataCite
NLM
NLM
DC
DC